BALYASNY ASSET MANAGEMENT L.P. - 31 Dec 2025 SCHEDULE 13G Report for Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share (CTNM)

Filing Manager: BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager: Balyasny Asset Management L.P.
Security: Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share
Symbol: CTNM
Shares outstanding: 30,431,579 shares
Disclosed Ownership: 2,312,800 shares
Ownership: 7.6%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 06:28:31 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
Balyasny Asset Management L.P.	7.6%	2,312,800	0	2,312,800	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
BAM GP LLC	7.6%	2,312,800	2,312,800	0	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP	7.6%	2,312,800	2,312,800	0	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dames GP LLC	7.6%	2,312,800	2,312,800	0	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dmitry Balyasny	7.6%	2,312,800	2,312,800	0	/s/ Dmitry Balyasny	Dmitry Balyasny / Self